DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Silicon dioxide is an investigational drug.
There have been 7 clinical trials for Silicon dioxide. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2011.
The most common disease conditions in clinical trials are Dentin Sensitivity, Diarrhea, and Hepatitis C. The leading clinical trial sponsors are German Federal Ministry of Education and Research, University of Milan, and UPECLIN HC FM Botucatu Unesp.
Recent Clinical Trials for Silicon dioxide
|Celiac Disease and Vitamin Status: Evaluation of the Effect of Supplementation With a Probiotic (VIVOMIXX®) in a Cohoort of Celiac Patients||University of Milan||Phase 4|
|Probiotics for Quality of Life in Autism Spectrum Disorders||Autism Speaks||Phase 0|
|Probiotics for Quality of Life in Autism Spectrum Disorders||Autism Treatment Network||Phase 0|